Partnerships

Ocera’s strategy is to build a robust product pipeline through licensing and acquisition of clinical programs.
Ocera focuses on programs that provide us with opportunities to:

• Expand into new therapeutic applications
• Expand into new geographic areas
• Introduce novel therapeutics for unmet medical needs through accelerated development paths

Ocera’s team is structured for highly efficient drug development, regulatory strategy and partnering. Ocera’s first partnership is with Kureha Corporation of Tokyo, Japan.

Contact:
Akiko Shibata
V.P. Business Operations
Ocera Therapeutics, Inc.
ashibata@ocerainc.com